Levitra 20 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

levitra 20 mg

orifarm as - vardenafilhydroklorid - tablett, filmdrasjert - 20 mg

Koselugo Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

koselugo

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiske midler - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.

Zoledronic Acid Oresund Pharma 5 mg/100 ml Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

zoledronic acid oresund pharma 5 mg/100 ml

oresund pharma aps - zoledronsyremonohydrat - infusjonsvæske, oppløsning - 5 mg/100 ml

Cardisure vet. 3.5 mg/ ml Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

cardisure vet. 3.5 mg/ ml

dechra veterinary products (1) - pimobendan - mikstur, oppløsning - 3.5 mg/ ml

Lunsumio Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - lymfom, follikulært - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Ebvallo Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Eladynos Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

eladynos

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalsiumhomeostase - behandling av osteoporose hos postmenopausale kvinner med økt risiko for brudd.